Easton Pharmaceuticals executives, John K. Easton and Mr. Lee Hendelson have mutually agreed to step down from the company. The company has accepted the resignations of Mr. John K. Easton from his position as Chief Executive officer and chairman of the board, and the resignation of Mr. Hendelson as Chief Financial officer allowing for both individuals to undertake other business opportunities. The company announced Mr. John Adams, age 53, a resident of the UK and the European Union, has accepted the position of Chief Executive officer and President, while Mr. Walter Falinski assumes the position of Chief Financial officer.

Mr. Adams possesses a strong background in the field of alternative therapies and treatments, as well as holding a strong belief that many common and serious ailments can be treated with non evasive natural herbal remedies.